Biotech Asks 1st Circ. To Undo Red Cross Antitrust Immunity

By Bryan Koenig · August 17, 2026, 3:15 PM EDT

A biotech firm asked the First Circuit on Friday to undo a district court decision granting the American Red Cross immunity from antitrust allegations, arguing the blood donation giant was wrongly...

To view the full article, register now.

Documents

Case Information

Case Title

Verax Biomedical Inc. v. American National Red Cross

Case Number

1:23-cv-10335

Court

Massachusetts

Nature of Suit

Anti-Trust

Date Filed

February 14, 2023


Case Title

Verax Biomedical Inc. v. American National Red Cross

Case Number

26-1511

Court

Appellate - 1st Circuit

Nature of Suit

3410 Antitrust

Date Filed

May 11, 2026